Skip to main navigation Skip to search Skip to main content

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients with Epidermolysis Bullosa

Project: Research

Project Details

StatusFinished
Effective start/end date07/13/1606/9/19

Funding

  • Scioderm: $30,783.13